Trial result ·
A second yearly booster dose of the VLA15 Lyme borreliosis vaccine candidate in healthy individuals.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This trial tested VLA15, a shot being studied against Lyme disease. People aged 5 to 65 were placed by chance into groups. One group got the shot at months 0, 2 and 6. Another got it at months 0 and 6, with a dummy shot at month 2. One more group got only dummy shots. The shot groups got extra boosters at months 18 and 30. This report covers months 19 to 31 of a phase 2 trial.
What they found
Antibody levels fell after the month 18 booster. Still, they stayed above the levels seen after the first shots. The month 30 booster raised antibody levels strongly again. This was seen for all the Lyme germ types and age groups. The responses showed signs of immune memory. Responses looked much like those after the month 18 booster. People coped with both boosters in a similar, acceptable way. No safety concerns came up through month 31.
What it means for patients
The authors say these results back a plan of first shots, then yearly boosters. They think yearly boosters may help keep up possible protection against Lyme disease. No shot for Lyme disease in people is on offer yet.
Why it is not certain yet
This trial looked at antibody levels, not whether people were kept from disease. The abstract does not give the number of people in the trial. It also does not give detailed side effect figures. This was a phase 2 trial, not a late-stage one. Results here cover only up to month 31.
The registered trial
The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.
Source
A second yearly booster dose of the VLA15 Lyme borreliosis vaccine candidate in healthy individuals.
PubMed · PMID 42680745We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Lyme disease publications